Dequalinium

DB04209ApprovedSmall moleculeAnti-Bacterial Agents

Dequalinium is a quaternary ammonium cation antimicrobial agent used to treat common infections of the mouth and throat, as well as vaginal candidiasis. Dequalinium is an antibacterial agent with multi-targeted actions.

Chemical structure of Dequalinium
Mechanism
Curator reviewed · 13 references
Primary indication
Dequalinium is used in several OTC products to treat mouth infections and inflammation, such as tonsillitis, pharyngitis, and gingivitis.Curator reviewed · 16 structured indications
Formula / weight
C30H40N4 · 456.6654 g/mol (avg)
First approval
Canada, 2021
Code names
LSM-5846

Resolves to

Structure
InChIKeyPCSWXVJAIHCTMO-UHFFFAOYSA-PSMILESCC1=CC(N)=C2C=CC=CC2=[N+]1CCCCCCCCCC[N+]1=C(C)C=C(N)C2=C1C=CC=C2
Transporters

What you can answer from here — as of September 23, 2026

13Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
54Drug interactionsStructured to mechanism, not free text
Sign in
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
16Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
3ContraindicationsEach with its own population and attribute set
Sign in
72Marketed productsAcross 9 countries and 44 labellers
Sign in
3ATC codesIncluding every combination product, plus 13 drug categories
Sign in
31+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Dequalinium, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account